Less common activating mutations of FGFR1, such as N546K and K656E, have been identified in dysembryoplastic neuroepithelial tumor (DNET),6 small cell lung cancer (SCLC),7 Ewing sarcoma,8 and in other cancers.9 This evidence concerns the gene FGFR1 and cancer.